Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | CA5A | P35218 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 2/20 | 0.30 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6038263 | 0.83 | SMN1; SMN2 (0.33) | SMN1; SMN2LMNAALOX15 | |
| SCHEMBL9460943 | 0.74 | FFAR3 (0.30) | — | |
| SCHEMBL30967694 | 0.74 | SMN1; SMN2 (0.43) | SMN1; SMN2KMT2ALMNACA2CA4 | |
| SCHEMBL1816299 | 0.69 | SMN1; SMN2 (0.33) | SMN1; SMN2NPSR1KMT2AL3MBTL1LMNA | |
| SCHEMBL57952 | 0.66 | NPSR1 (0.49) | SMN1; SMN2NPSR1KMT2AL3MBTL1LMNA | |
| SCHEMBL21599089 | 0.63 | SMN1; SMN2 (0.33) | SMN1; SMN2NPSR1KMT2AL3MBTL1LMNA | |
| SCHEMBL24158115 | 0.61 | SMN1; SMN2 (0.32) | SMN1; SMN2NPSR1KMT2AL3MBTL1LMNA | |
| SCHEMBL8847094 | 0.60 | KMT2A (0.53) | KMT2AL3MBTL1LMNACA2CA4 | |
| SCHEMBL22228993 | 0.60 | CA2 (0.62) | NPSR1KMT2AL3MBTL1CA2CA4 | |
| SCHEMBL27895861 | 0.60 | CA2 (0.55) | NPSR1KMT2AL3MBTL1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250187036-A1 | METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA | SICPA HOLDING SA (CH) | 2025-06-12 | — | — | US | claimed |
| CN-119677597-A | Method for producing an optical effect layer comprising magnetic or magnetizable pigment particles and exhibiting more than one marking | 锡克拜控股有限公司 | 2025-03-21 | — | — | CN | claimed |
| WO-2025027017-A1 | UV-LED CURABLE VISCOUS PRINTING INKS AND PRINTING PROCESSES | SICPA HOLDING SA (CH) | 2025-02-06 | — | — | WO | claimed |
| EP-4486515-A1 | METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA | Sicpa Holding SA (CH) | 2025-01-08 | — | — | EP | claimed |
| CN-118829493-A | Method for producing an optical effect layer comprising magnetic or magnetizable pigment particles and exhibiting more than one marking | 锡克拜控股有限公司 | 2024-10-22 | — | — | CN | claimed |
| WO-2023161464-A1 | METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA | SICPA HOLDING SA (CH) | 2023-08-31 | — | — | WO | claimed |
| EP-4565378-B1 | METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA | SICPA HOLDING SA (CH) | 2026-05-06 | — | — | EP | disclosed |
| US-20260035579-A1 | RYLENE-BASED UV CURABLE SECURITY INK COMPOSITIONS | SICPA HOLDING SA (CH) | 2026-02-05 | — | — | US | disclosed |
| US-20260015799-A1 | METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA | SICPA HOLDING SA (CH) | 2026-01-15 | — | — | US | disclosed |
| EP-4612244-A1 | RYLENE-BASED UV CURABLE SECURITY INK COMPOSITIONS | Sicpa Holding SA (CH) | 2025-09-10 | — | — | EP | disclosed |
| CN-120202260-A | Rylene-based UV curable security ink composition | 锡克拜控股有限公司 | 2025-06-24 | — | — | CN | disclosed |
| US-20250187036-A1 | METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA | SICPA HOLDING SA (CH) | 2025-06-12 | — | — | US | disclosed |
| CN-119677597-A | Method for producing an optical effect layer comprising magnetic or magnetizable pigment particles and exhibiting more than one marking | 锡克拜控股有限公司 | 2025-03-21 | — | — | CN | disclosed |
| WO-2025027017-A1 | UV-LED CURABLE VISCOUS PRINTING INKS AND PRINTING PROCESSES | SICPA HOLDING SA (CH) | 2025-02-06 | — | — | WO | disclosed |
| EP-4486515-A1 | METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA | Sicpa Holding SA (CH) | 2025-01-08 | — | — | EP | disclosed |
| CN-118829493-A | Method for producing an optical effect layer comprising magnetic or magnetizable pigment particles and exhibiting more than one marking | 锡克拜控股有限公司 | 2024-10-22 | — | — | CN | disclosed |
| WO-2024094829-A1 | RYLENE-BASED UV CURABLE SECURITY INK COMPOSITIONS | SICPA HOLDING SA (CH) | 2024-05-10 | — | — | WO | disclosed |
| WO-2023161464-A1 | METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA | SICPA HOLDING SA (CH) | 2023-08-31 | — | — | WO | disclosed |
| EP-3292972-A1 | PRE-COATING SUBSTRATES WITH A COPY OF A MATRIX SURFACE USING A RADIATION-CURABLE MATERIAL | Baptista, Valter Marques (BR) | 2018-03-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015799-A1 | METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA | IK, TEX10, INCENP | SMN1; SMN2 1005/4885NPSR1 4527/4885KMT2A 3140/4885 |
| US-20260035579-A1 | RYLENE-BASED UV CURABLE SECURITY INK COMPOSITIONS | RB1, CDK1, MARK1 | SMN1; SMN2 3149/4885NPSR1 3913/4885KMT2A 964/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.